Rosetta Genomics Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ROSGQ has 5.93 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 5.93M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +14.43% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 2.23.
| Current Ratio | 2.09 |
| Quick Ratio | 0.85 |
| Debt / Equity | 2.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.21 |
| Interest Coverage | -15.47 |
Financial Efficiency
Return on equity (ROE) is -137.95% and return on invested capital (ROIC) is -81.02%.
| Return on Equity (ROE) | -137.95% |
| Return on Assets (ROA) | -60.19% |
| Return on Invested Capital (ROIC) | -81.02% |
| Return on Capital Employed (ROCE) | -303.29% |
| Revenue Per Employee | 33,244 |
| Profits Per Employee | -155,698 |
| Employee Count | 86 |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 15.54 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 72.70 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, ROSGQ had revenue of 2.86 million and -13.39 million in losses. Loss per share was -6.41.
| Revenue | 2.86M |
| Gross Profit | 962,000 |
| Operating Income | -10.59M |
| Pretax Income | -9.53M |
| Net Income | -13.39M |
| EBITDA | -10.35M |
| EBIT | -10.59M |
| Loss Per Share | -6.41 |
Balance Sheet
The company has 1.33 million in cash and 2.45 million in debt, giving a net cash position of -1.12 million or -0.19 per share.
| Cash & Cash Equivalents | 1.33M |
| Total Debt | 2.45M |
| Net Cash | -1.12M |
| Net Cash Per Share | -0.19 |
| Equity (Book Value) | 1.10M |
| Book Value Per Share | 0.42 |
| Working Capital | 2.97M |
Cash Flow
In the last 12 months, operating cash flow was -11.68 million and capital expenditures -44,000, giving a free cash flow of -11.73 million.
| Operating Cash Flow | -11.68M |
| Capital Expenditures | -44,000 |
| Free Cash Flow | -11.73M |
| FCF Per Share | -1.98 |
Margins
| Gross Margin | 33.65% |
| Operating Margin | -370.55% |
| Pretax Margin | -333.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ROSGQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.34% |
| Shareholder Yield | -34.34% |
| Earnings Yield | -2,258,010.12% |
| FCF Yield | -1,977,740.30% |
Stock Splits
The last stock split was on March 17, 2017. It was a reverse split with a ratio of 0.0833333.
| Last Split Date | Mar 17, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.0833333 |
Scores
ROSGQ has an Altman Z-Score of -39.46. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -39.46 |
| Piotroski F-Score | n/a |